ER&D services largest pure-play, Alten, has ambitions as a clinical trials contract research organization (CRO). During Q2 2021, the company completed the acquisition of Cmed. Cmed, a clinical trial CRO based in the UK. It is a small firm with EUR 20m in revenues and 180 consultants. It has specialized in oncology, immuno-oncology, cell therapy, and rare disease.
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.
Icon made a step change in the clinical trials CRO market with its USD 12bn planned PRA Health Sciences acquisition. The purpose of the transaction is scale. With PRA Health Services, Icon will double its size.
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.